Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: results from the Danish Renal Cancer Group (DARENCA) study-2. | Eur J Cancer | 2013 | 0.91 |